Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TADALAFIL Cause Therapeutic product effect incomplete? 81 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Therapeutic product effect incomplete have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.3% of all adverse event reports for TADALAFIL.

81
Reports of Therapeutic product effect incomplete with TADALAFIL
0.3%
of all TADALAFIL reports
7
Deaths
50
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From TADALAFIL?

Of the 81 reports, 7 (8.6%) resulted in death, 50 (61.7%) required hospitalization, and 7 (8.6%) were considered life-threatening.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 81 reports have been filed with the FAERS database.

What Other Side Effects Does TADALAFIL Cause?

Headache (3,196) Drug ineffective (2,943) Dyspnoea (2,881) Death (1,917) Diarrhoea (1,667) Dizziness (1,374) Nausea (1,368) Asthenia (1,230) Fatigue (1,135) Hypertension (1,044)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which TADALAFIL Alternatives Have Lower Therapeutic product effect incomplete Risk?

TADALAFIL vs TAFAMIDIS TADALAFIL vs TAFAMIDIS MEGLUMINE TADALAFIL vs TAFASITAMAB TADALAFIL vs TAFASITAMAB-CXIX TADALAFIL vs TAFINLAR

Related Pages

TADALAFIL Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete TADALAFIL Demographics